---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-021383"
form_type: "8-K"
ticker: "ETON"
cik: "0001710340"
company_name: "Eton Pharmaceuticals, Inc."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T16:08:58.620834+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Eton Pharmaceuticals added to Russell 2000 and Russell 3000 Indexes

## Summary
- Effective after market close June 27, 2025 as part of 2025 annual reconstitution.
- CEO Sean Brynjelsen called it a significant milestone recognizing shareholder value.
- Addition expands visibility among index fund managers and institutional investors.

## SEC filing metadata
- accession: 0001437749-25-021383
- form_type: 8-K
- ticker: ETON
- cik: 0001710340
- company_name: Eton Pharmaceuticals, Inc.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1710340/000143774925021383/0001437749-25-021383-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1710340/000143774925021383/eton20250625_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-021383
- JSON: https://secwatch.observer/filing/0001437749-25-021383.json
- Plain text: https://secwatch.observer/filing/0001437749-25-021383.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.